Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial.

Saved in:
Bibliographic Details
Title: Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial.
Authors: Berk JL; Amyloidosis Center, Departments of Medicine and Neurology, Boston University School of Medicine, Boston, Massachusetts., Suhr OB; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden., Obici L; Amyloidosis Research and Treatment Center, Foundation IRCCS Policlinico San Matteo and Department of Molecular Medicine, University of Pavia, Pavia, Italy., Sekijima Y; Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan., Zeldenrust SR; Departments of Medicine and Neurology, Mayo Clinic, Rochester, Minnesota., Yamashita T; Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan., Heneghan MA; Institute of Liver Studies, King's College Hospital Foundation Trust, London, England., Gorevic PD; Departments of Medicine and Neurology, Mount Sinai School of Medicine, New York, New York., Litchy WJ; Departments of Medicine and Neurology, Mayo Clinic, Rochester, Minnesota., Wiesman JF; Amyloidosis Center, Departments of Medicine and Neurology, Boston University School of Medicine, Boston, Massachusetts., Nordh E; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden., Corato M; Istituto Clinico Humanitas, Rozzano, Italy., Lozza A; C. Mondino National Institute of Neurology, Foundation IRCCS, Pavia, Italy., Cortese A; C. Mondino National Institute of Neurology, Foundation IRCCS, Pavia, Italy., Robinson-Papp J; Departments of Medicine and Neurology, Mount Sinai School of Medicine, New York, New York., Colton T; Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts., Rybin DV; Data Coordinating Center, Boston University School of Public Health, Boston, Massachusetts., Bisbee AB; Data Coordinating Center, Boston University School of Public Health, Boston, Massachusetts., Ando Y; Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan., Ikeda S; Department of Medicine, Shinshu University School of Medicine, Matsumoto, Japan., Seldin DC; Amyloidosis Center, Departments of Medicine and Neurology, Boston University School of Medicine, Boston, Massachusetts., Merlini G; Amyloidosis Research and Treatment Center, Foundation IRCCS Policlinico San Matteo and Department of Molecular Medicine, University of Pavia, Pavia, Italy., Skinner M; Amyloidosis Center, Departments of Medicine and Neurology, Boston University School of Medicine, Boston, Massachusetts., Kelly JW; Departments of Chemistry and Molecular and Experimental Medicine and Skaggs Institute of Chemical Biology, Scripps Research Institute, La Jolla, California., Dyck PJ; Departments of Medicine and Neurology, Mayo Clinic, Rochester, Minnesota.
Corporate Authors: Diflunisal Trial Consortium
Source: JAMA [JAMA] 2013 Dec 25; Vol. 310 (24), pp. 2658-67.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-3598
DOI:10.1001/jama.2013.283815